Publications found:
55,654
Sort by:
Enterocolitis - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... action and recent developments associated with each drug. Companies participating in Enterocolitis pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Enterocolitis pipeline and treatment landscape Complete list of drug candidates from discovery to pre- ...
April 2019
43 pages
Eosinophilic Esophagitis - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... associated with each drug. Companies participating in Eosinophilic Esophagitis pipeline Profiled in detail Key ... Eosinophilic Esophagitis treatment pipeline. The report includes: The research work provides comprehensive overview of Eosinophilic Esophagitis pipeline and treatment landscape Complete list of drug ...
April 2019
61 pages
Erectile Dysfunction - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... developments associated with each drug. Companies participating in Erectile Dysfunction pipeline Profiled in detail Key ... Erectile Dysfunction treatment pipeline. The report includes: The research work provides comprehensive overview of Erectile Dysfunction pipeline and treatment landscape Complete list of drug ...
April 2019
98 pages
Exocrine Pancreatic Insufficiency - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... assists users in taking actionable steps Exocrine Pancreatic Insufficiency pipeline report enables users to gain clear understanding ... in Exocrine Pancreatic Insufficiency treatment pipeline. The report includes: The research work provides comprehensive overview of Exocrine Pancreatic Insufficiency pipeline and ...
April 2019
45 pages
Familial Amyloid Neuropathies - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... Report assists users in taking actionable steps Familial Amyloid Neuropathies pipeline report enables users to gain clear understanding ... in Familial Amyloid Neuropathies treatment pipeline. The report includes: The research work provides comprehensive overview of Familial Amyloid Neuropathies pipeline and ...
April 2019
50 pages
Female Contraception - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... developments associated with each drug. Companies participating in Female Contraception pipeline Profiled in detail Key ... Female Contraception treatment pipeline. The report includes: The research work provides comprehensive overview of Female Contraception pipeline and treatment landscape Complete list of drug ...
April 2019
70 pages
Female Hypoactive Sexual Desire Disorder - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... with each drug. Companies participating in Female Hypoactive Sexual Desire Disorder pipeline Profiled in detail Key players actively ... Female Hypoactive Sexual Desire Disorder treatment pipeline. The report includes: The research work provides comprehensive overview of Female Hypoactive Sexual Desire Disorder ...
April 2019
51 pages
Female Sexual Dysfunction - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... Report assists users in taking actionable steps Female Sexual Dysfunction pipeline report enables users to gain clear understanding ... business in Female Sexual Dysfunction treatment pipeline. The report includes: The research work provides comprehensive overview of Female Sexual Dysfunction pipeline and ...
April 2019
59 pages
Functional (NonUlcer) Dyspepsia - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... assists users in taking actionable steps Functional (NonUlcer) Dyspepsia pipeline report enables users to gain clear understanding ... in Functional (NonUlcer) Dyspepsia treatment pipeline. The report includes: The research work provides comprehensive overview of Functional (NonUlcer) Dyspepsia pipeline and ...
April 2019
40 pages
Gastric Ulcers - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... developments, pharmacological action and recent developments associated with each drug. Companies participating in Gastric Ulcers pipeline Profiled in detail Key players actively participating in constipation ...
April 2019
45 pages
Gastritis - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... action and recent developments associated with each drug. Companies participating in Gastritis pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Gastritis pipeline and treatment landscape Complete list of drug candidates from discovery to pre-registration ...
April 2019
60 pages
Gastroenteritis - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... action and recent developments associated with each drug. Companies participating in Gastroenteritis pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Gastroenteritis pipeline and treatment landscape Complete list of drug candidates from discovery to pre- ...
April 2019
47 pages
Gastroesophageal Reflux Disease - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... assists users in taking actionable steps Gastroesophageal Reflux Disease pipeline report enables users to gain clear understanding ... in Gastroesophageal Reflux Disease treatment pipeline. The report includes: The research work provides comprehensive overview of Gastroesophageal Reflux Disease pipeline and ...
April 2019
76 pages
Glomerulonephritis - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... and recent developments associated with each drug. Companies participating in Glomerulonephritis pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Glomerulonephritis pipeline and treatment landscape Complete list of drug candidates from discovery to pre- ...
April 2019
150 pages
Grass Pollen Allergy - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... . Report assists users in taking actionable steps Grass Pollen Allergy pipeline report enables users to gain clear understanding into ... business in Grass Pollen Allergy treatment pipeline. The report includes: The research work provides comprehensive overview of Grass Pollen Allergy pipeline and treatment ...
April 2019
50 pages
Graves Diseases - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... developments, pharmacological action and recent developments associated with each drug. Companies participating in Graves Diseases pipeline Profiled in detail Key players actively participating in constipation ...
April 2019
39 pages
Hereditary Angioedema (HAE) - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... Report assists users in taking actionable steps Hereditary Angioedema (HAE) pipeline report enables users to gain clear understanding ... business in Hereditary Angioedema (HAE) treatment pipeline. The report includes: The research work provides comprehensive overview of Hereditary Angioedema (HAE) pipeline and ...
April 2019
68 pages
Homozygous Familial Hypercholesterolemia (HoFH) - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... each drug. Companies participating in Homozygous Familial Hypercholesterolemia (HoFH) pipeline Profiled in detail Key ... Homozygous Familial Hypercholesterolemia (HoFH) treatment pipeline. The report includes: The research work provides comprehensive overview of Homozygous Familial Hypercholesterolemia (HoFH ...
April 2019
58 pages
House Dust Mite Allergy - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... developments associated with each drug. Companies participating in House Dust Mite Allergy pipeline Profiled in detail Key players actively participating ... in House Dust Mite Allergy treatment pipeline. The report includes: The research work provides comprehensive overview of House Dust Mite Allergy pipeline ...
April 2019
54 pages
Hyperinsulinemia - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... action and recent developments associated with each drug. Companies participating in Hyperinsulinemia pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Hyperinsulinemia pipeline and treatment landscape Complete list of drug candidates from discovery to pre- ...
April 2019
50 pages
Hyperuricemia - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... action and recent developments associated with each drug. Companies participating in Hyperuricemia pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Hyperuricemia pipeline and treatment landscape Complete list of drug candidates from discovery to pre- ...
April 2019
60 pages
Hypoglycemia - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... action and recent developments associated with each drug. Companies participating in Hypoglycemia pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Hypoglycemia pipeline and treatment landscape Complete list of drug candidates from discovery to pre- ...
April 2019
62 pages
Hypoparathyroidism - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... and recent developments associated with each drug. Companies participating in Hypoparathyroidism pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Hypoparathyroidism pipeline and treatment landscape Complete list of drug candidates from discovery to pre- ...
April 2019
52 pages
Hypothyroidism - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... action and recent developments associated with each drug. Companies participating in Hypothyroidism pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Hypothyroidism pipeline and treatment landscape Complete list of drug candidates from discovery to pre- ...
April 2019
41 pages
Insulin Resistance - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... developments associated with each drug. Companies participating in Insulin Resistance pipeline Profiled in detail Key ... Insulin Resistance treatment pipeline. The report includes: The research work provides comprehensive overview of Insulin Resistance pipeline and treatment landscape Complete list of drug ...
April 2019
50 pages
Irritable Bowel Syndrome - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... Report assists users in taking actionable steps Irritable Bowel Syndrome pipeline report enables users to gain clear understanding ... business in Irritable Bowel Syndrome treatment pipeline. The report includes: The research work provides comprehensive overview of Irritable Bowel Syndrome pipeline and treatment ...
April 2019
125 pages
Kidney Fibrosis - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... developments, pharmacological action and recent developments associated with each drug. Companies participating in Kidney Fibrosis pipeline Profiled in detail Key players actively participating in constipation ...
April 2019
130 pages
Kidney Transplant Rejection - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... Report assists users in taking actionable steps Kidney Transplant Rejection pipeline report enables users to gain clear understanding ... business in Kidney Transplant Rejection treatment pipeline. The report includes: The research work provides comprehensive overview of Kidney Transplant Rejection pipeline and ...
April 2019
145 pages
Liver Cirrhosis - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... developments, pharmacological action and recent developments associated with each drug. Companies participating in Liver Cirrhosis pipeline Profiled in detail Key players actively participating in constipation ...
April 2019
89 pages
Liver Failure (Hepatic Insufficiency) - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... associated with each drug. Companies participating in Liver Failure (Hepatic Insufficiency) pipeline Profiled in detail Key players ... Liver Failure (Hepatic Insufficiency) treatment pipeline. The report includes: The research work provides comprehensive overview of Liver Failure (Hepatic Insufficiency) ...
April 2019
90 pages
Liver Transplant Rejection - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... Report assists users in taking actionable steps Liver Transplant Rejection pipeline report enables users to gain clear understanding ... business in Liver Transplant Rejection treatment pipeline. The report includes: The research work provides comprehensive overview of Liver Transplant Rejection pipeline and ...
April 2019
57 pages
Lung Transplant Rejection - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... Report assists users in taking actionable steps Lung Transplant Rejection pipeline report enables users to gain clear understanding ... business in Lung Transplant Rejection treatment pipeline. The report includes: The research work provides comprehensive overview of Lung Transplant Rejection pipeline and ...
April 2019
60 pages
Male Hypogonadism - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... developments associated with each drug. Companies participating in Male Hypogonadism pipeline Profiled in detail Key players ... Male Hypogonadism treatment pipeline. The report includes: The research work provides comprehensive overview of Male Hypogonadism pipeline and treatment landscape Complete list of drug ...
April 2019
70 pages
Male Infertility - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... developments, pharmacological action and recent developments associated with each drug. Companies participating in Male Infertility pipeline Profiled in detail Key players actively participating in constipation ...
April 2019
38 pages
Myasthenia Gravis - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... developments associated with each drug. Companies participating in Myasthenia Gravis pipeline Profiled in detail Key players ... Myasthenia Gravis treatment pipeline. The report includes: The research work provides comprehensive overview of Myasthenia Gravis pipeline and treatment landscape Complete list of drug ...
April 2019
99 pages
Nephrotic Syndrome - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... developments associated with each drug. Companies participating in Nephrotic Syndrome pipeline Profiled in detail Key ... Nephrotic Syndrome treatment pipeline. The report includes: The research work provides comprehensive overview of Nephrotic Syndrome pipeline and treatment landscape Complete list of drug ...
April 2019
40 pages
Nocturia - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... action and recent developments associated with each drug. Companies participating in Nocturia pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Nocturia pipeline and treatment landscape Complete list of drug candidates from discovery to pre-registration ...
April 2019
45 pages
Oral Mucositis - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... developments, pharmacological action and recent developments associated with each drug. Companies participating in Oral Mucositis pipeline Profiled in detail Key players actively participating in constipation ...
April 2019
76 pages
Overactive Bladder - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... developments associated with each drug. Companies participating in Overactive Bladder pipeline Profiled in detail Key ... Overactive Bladder treatment pipeline. The report includes: The research work provides comprehensive overview of Overactive Bladder pipeline and treatment landscape Complete list of drug ...
April 2019
89 pages
Pancreatitis - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... action and recent developments associated with each drug. Companies participating in Pancreatitis pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Pancreatitis pipeline and treatment landscape Complete list of drug candidates from discovery to pre- ...
April 2019
92 pages
Peanut Allergy - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... developments, pharmacological action and recent developments associated with each drug. Companies participating in Peanut Allergy pipeline Profiled in detail Key players actively participating in constipation ...
April 2019
122 pages
Pemphigus Vulgaris - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... developments associated with each drug. Companies participating in Pemphigus Vulgaris pipeline Profiled in detail Key ... Pemphigus Vulgaris treatment pipeline. The report includes: The research work provides comprehensive overview of Pemphigus Vulgaris pipeline and treatment landscape Complete list of drug ...
April 2019
52 pages
Peptic Ulcers - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... developments, pharmacological action and recent developments associated with each drug. Companies participating in Peptic Ulcers pipeline Profiled in detail Key players actively participating in constipation ...
April 2019
55 pages
Peritonitis - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... action and recent developments associated with each drug. Companies participating in Peritonitis pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Peritonitis pipeline and treatment landscape Complete list of drug candidates from discovery to pre- ...
April 2019
45 pages
Phenylketonuria (PKU) - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... associated with each drug. Companies participating in Phenylketonuria (PKU) pipeline Profiled in detail Key ... Phenylketonuria (PKU) treatment pipeline. The report includes: The research work provides comprehensive overview of Phenylketonuria (PKU) pipeline and treatment landscape Complete list of drug ...
April 2019
69 pages
Pituitary ACTH Hypersecretion (Cushing Disease) - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... each drug. Companies participating in Pituitary ACTH Hypersecretion (Cushing Disease) pipeline Profiled in detail Key ... Pituitary ACTH Hypersecretion (Cushing Disease) treatment pipeline. The report includes: The research work provides comprehensive overview of Pituitary ACTH Hypersecretion (Cushing Disease ...
April 2019
45 pages
Polycystic Ovarian Syndrome - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... Report assists users in taking actionable steps Polycystic Ovarian Syndrome pipeline report enables users to gain clear understanding ... business in Polycystic Ovarian Syndrome treatment pipeline. The report includes: The research work provides comprehensive overview of Polycystic Ovarian Syndrome pipeline and ...
April 2019
40 pages
Pompe Disease - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... developments, pharmacological action and recent developments associated with each drug. Companies participating in Pompe Disease pipeline Profiled in detail Key players actively participating in constipation ...
April 2019
69 pages
